The Focused Ultrasound Foundation, Philips Healthcare, and focused-ultrasound developer InSightec have joined forces to establish an international multicenter registry to evaluate MR-guided focused ultrasound treatment for uterine fibroids.
RELIEF (Registry for Leiomyoma: International Efficacy of Focused Ultrasound) will start collecting data in the second half of 2013. Over a three-year period, the registry will collect data from 1,000 women who receive focused ultrasound treatment from one of more than 30 treatment sites.
The resulting database is intended to provide large-scale evidence of the safety, efficacy, and long-term durability of the treatment, according to the Focused Ultrasound Foundation. The goal is to drive rapid physician acceptance of this treatment and to facilitate reimbursement.
